7 January 2021

Nael Nadif Kasri, Department of Cognitive Neurosciences, Human Genetics theme Neurodevelopmental disorders, received 250,000 Euro as a member of the SCN1A-UP! consortium. The latter is funded by the European Joint Programme on Rare Diseases (EJP-RD), which brings together over 130 institutions from 35 countries and focuses on pre-clinical research to develop effective therapies for rare diseases.

The SCN1A-UP!  project will run for three years, receiving a total of 1.5 million Euro in funding, and aims at developing therapeutic approaches, based on novel gene therapy tools, for SCN1A-related epilepsies.

SCN1A-UP!  involves five academic partners from France (ANR, University of Cote d’Azur), Italy (Institute of Neuroscience, CNR, Italy), Belgium (University of Leuven), Germany (University of Tübingen). Other participants include collaborators (Netherlands, University of Amsterdam) and patient organizations in the Netherlands, France and Italy.

At Radboudumc, the work will focus on the use of induced pluripotent stem cells for screening and testing of novel gene therapies to restore the neuronal properties of patient-derived neurons.

EJP-RD link:  https://www.ejprarediseases.org/index.php/funded-projects-2020/

Related news items


Radboud Young Academy safeguards the future of science

21 January 2021

New platform to provide advice on policy, create an interdisciplinary network of early career scientists, and promote career development.

read more

Increase radio- and immunotherapy efficacy by targeting hypoxia

21 January 2021

In a paper recently accepted by Clinical Cancer Research, Daan Boreel, together with Paul Span, Sandra Heskamp, Gosse Adema and Jan Bussink, reviews the therapeutic potential of decreasing the lack of oxygen (hypoxia) often found in solid tumors.

read more

Radiation boost lowers risk of prostate cancer recurrence

21 January 2021

An additional external-beam radiation dose delivered directly to the tumor can benefit the prospects of men with non-metastatic prostate cancer, without causing additional side effects. The risk of relapse within five years for these men is smaller than for men who did not receive this boost.

read more

New research through grants for Radboudumc researchers

14 January 2021

Several researchers at the Radboudumc have received grants to start new studies, including on rare diseases, liver disease and cancer metastases. These are grants from the Dutch Research Council, European Joint Programme on Rare Diseases and the Gastric Liver Disease Foundation.

read more

Should we prepare for a corona-related depression wave? Indira Tendolkar and Eric Ruhé talk about their research projects

13 January 2021

Since the outbreak of the SARS-CoV-2, many of us have been staying at home in order to limit our social interactions, to keep ourselves and others safe from the virus. Yet, there’s also concern about what social distancing and anxiety generated by media reports are doing to people's mental health.

read more

RIMLS online award ceremony proudly presenting the winners

13 January 2021

In this special webinar of the RIMLS New Year Celebration, scientific director René Bindels reviewed 2020 and looked forward to 2021. But more importantly a number of researchers received prizes in the traditional RIMLS awards ceremony. 

read more